ls -la /home/daytona/workspace/

mkdir -p /home/daytona/workspace/qa-qc-clinical-trial

~/qa-qc-clinical-trial/create_ppt.js

node /home/daytona/workspace/qa-qc-clinical-trial/create_ppt.js

ls -la /home/daytona/workspace/ && ls -la /home/daytona/workspace/qa-qc-clinical-trial/ && python - << 'PY' import os print(os.path.exists('/home/daytona/workspace/qa-qc-clinical-trial/create_ppt.js')) PY

cat > /home/daytona/workspace/qa-qc-clinical-trial/create_ppt_20plus.js << 'EOF' const pptxgen = require('pptxgenjs'); const pptx = new pptxgen(); pptx.layout = 'LAYOUT_WIDE'; pptx.author = 'Orris'; pptx.company = 'Clinical Research Learning'; pptx.subject = 'Quality Assurance and Quality Control in Clinical Research Trials'; pptx.title = 'Quality Assurance and Quality Control in Clinical Research Trials'; pptx.lang = 'en-US'; pptx.theme = { headFontFace: 'Calibri', bodyFontFace: 'Calibri', lang: 'en-US' }; const colors = { bgDark: '0B1F3A', bgLight: 'F4F7FB', primary: '1F5AA6', secondary: '2E8B57', accent: 'F39C12', danger: 'C0392B', textDark: '1F2937', textLight: 'FFFFFF', muted: '6B7280', line: 'D1D9E6' }; function addHeader(slide, title, subtitle = '') { slide.addShape(pptx.ShapeType.rect, { x: 0, y: 0, w: 13.3, h: 0.9, fill: { color: colors.bgDark }, line: { color: colors.bgDark } }); slide.addText(title, { x: 0.5, y: 0.18, w: 11.8, h: 0.4, fontSize: 22, bold: true, color: colors.textLight, margin: 0 }); if (subtitle) { slide.addText(subtitle, { x: 0.5, y: 0.55, w: 12, h: 0.2, fontSize: 11, color: 'C7D2E5', margin: 0 }); } slide.addShape(pptx.ShapeType.line, { x: 0, y: 0.9, w: 13.3, h: 0, line: { color: colors.accent, pt: 2 } }); } function addFooter(slide, text = 'Clinical Research Quality Systems') { slide.addShape(pptx.ShapeType.rect, { x: 0, y: 7.1, w: 13.3, h: 0.4, fill: { color: 'E9EEF7' }, line: { color: 'E9EEF7' } }); slide.addText(text, { x: 0.5, y: 7.2, w: 12, h: 0.2, fontSize: 9, color: colors.muted, margin: 0 }); } function addBulletSlide(title, bullets, subtitle = '') { const slide = pptx.addSlide(); slide.background = { color: colors.bgLight }; addHeader(slide, title, subtitle); slide.addShape(pptx.ShapeType.roundRect, { x: 0.9, y: 1.35, w: 11.5, h: 5.6, rectRadius: 0.06, fill: { color: 'FFFFFF' }, line: { color: colors.line, pt: 1 } }); slide.addText(bullets.map((b, i) => ({ text: b, options: { bullet: { indent: 18 }, breakLine: i < bullets.length - 1 } })), { x: 1.3, y: 1.8, w: 10.8, h: 4.9, fontSize: 18, color: colors.textDark, paraSpaceAfterPt: 14 }); addFooter(slide); } // 1 Title { const slide = pptx.addSlide(); slide.background = { color: colors.bgDark }; slide.addShape(pptx.ShapeType.roundRect, { x: 0.8, y: 1.1, w: 11.7, h: 4.9, rectRadius: 0.08, fill: { color: '12345A' }, line: { color: '2D4C73', pt: 1 } }); slide.addText('QUALITY ASSURANCE & QUALITY CONTROL', { x: 1.2, y: 2.1, w: 10.9, h: 0.9, fontSize: 42, bold: true, color: 'FFFFFF', align: 'center' }); slide.addText('IN CLINICAL RESEARCH TRIALS', { x: 1.2, y: 3.15, w: 10.9, h: 0.6, fontSize: 26, color: 'D6E1F2', align: 'center' }); slide.addShape(pptx.ShapeType.line, { x: 3.3, y: 4.0, w: 6.7, h: 0, line: { color: colors.accent, pt: 2 } }); slide.addText('Comprehensive 20+ Slide Training Deck', { x: 1.2, y: 4.3, w: 10.9, h: 0.4, fontSize: 15, color: 'C7D2E5', align: 'center' }); slide.addText('Prepared for Clinical Research Teams', { x: 1.2, y: 6.45, w: 10.9, h: 0.3, fontSize: 12, color: 'AABAD4', align: 'center' }); } // 2 Agenda addBulletSlide('Agenda', [ 'Why quality matters in clinical trials', 'QA vs QC: definitions, scope, and accountability', 'Regulatory landscape and inspection expectations', 'Quality by Design (QbD) and risk-based quality management', 'QA and QC activities across the full trial lifecycle', 'Vendor/CRO oversight and digital system controls', 'Metrics, KPIs/KRIs, CAPA, and continuous improvement', 'Case scenarios, best practices, and final takeaways' ], 'Topics covered in this expanded presentation'); // 3-22 Content slides addBulletSlide('Why Quality Matters', [ 'Participant rights, safety, and well-being are the highest priority.', 'Reliable quality systems protect scientific validity and decision-making.', 'Regulators and ethics committees expect demonstrable control of trial processes.', 'Strong quality reduces rework, delays, budget overruns, and compliance risk.' ]); addBulletSlide('Quality Assurance (QA): Definition and Purpose', [ 'QA is process-focused and preventive.', 'QA establishes systems, standards, and governance before issues occur.', 'Core QA elements include SOPs, training, audits, and quality plans.', 'Goal: confidence that trial conduct will consistently meet requirements.' ]); addBulletSlide('Quality Control (QC): Definition and Purpose', [ 'QC is output-focused and detective.', 'QC verifies whether tasks and deliverables meet predefined standards.', 'Examples: source data checks, data validation, TMF review, reconciliation.', 'Goal: identify and correct defects before they impact decisions or safety.' ]); addBulletSlide('QA vs QC: Practical Differences', [ 'Timing: QA is built-in upfront; QC is performed during/after execution.', 'Focus: QA improves process capability; QC detects specific defects.', 'Ownership: QA by quality function and leadership; QC by operational teams.', 'Together, QA + QC create a closed-loop quality system.' ]); addBulletSlide('Regulatory Foundations', [ 'ICH E6(R2/R3) GCP: risk-based quality management and sponsor oversight.', '21 CFR Part 312/812: trial conduct, monitoring, and record controls.', '21 CFR Part 11: validated electronic systems and audit trails.', 'EU CTR 536/2014: harmonized clinical trial regulation across EU.' ]); addBulletSlide('ALCOA+ Data Integrity Principles', [ 'Attributable: clear ownership of every data entry/change.', 'Legible, contemporaneous, original, accurate (ALCOA).', 'Plus complete, consistent, enduring, and available.', 'Data integrity failures are among the most common inspection observations.' ]); addBulletSlide('Quality by Design (QbD)', [ 'Quality should be designed into protocol and operations from the start.', 'Identify critical-to-quality (CtQ) factors early.', 'Focus controls on high-risk processes rather than low-value routine checks.', 'Use multidisciplinary input: clinical, data, safety, statistics, operations.' ]); addBulletSlide('Risk-Based Quality Management (RBQM)', [ 'Perform structured risk assessment: likelihood, impact, detectability.', 'Define KRIs and quality tolerance limits (QTLs).', 'Use centralized monitoring to detect trends early.', 'Escalate and mitigate risks before they become major findings.' ]); addBulletSlide('QA in Study Start-Up', [ 'Protocol quality review and feasibility challenge sessions.', 'Site qualification standards and investigator due diligence.', 'Vendor/CRO qualification, contracts, and role clarity.', 'Training matrix completion before first participant enrollment.' ]); addBulletSlide('QC During Study Conduct', [ 'Informed consent form completeness and version control checks.', 'Source data verification/review based on risk strategy.', 'Protocol deviation detection, classification, and follow-up.', 'Safety reporting timeliness (SAE/SUSAR) and reconciliation.' ]); addBulletSlide('Data Management Quality Controls', [ 'Edit checks, discrepancy management, and query aging control.', 'Medical coding quality (WHO-Drug/MedDRA) and consistency checks.', 'Database lock readiness criteria and audit trail review.', 'Cross-functional data review meetings to resolve critical issues.' ]); addBulletSlide('TMF and Documentation Quality', [ 'TMF completeness, accuracy, and timeliness are inspection-critical.', 'Expected document list should be current and role-assigned.', 'Periodic TMF QC prevents end-of-study reconciliation crises.', 'Document metadata quality is as important as document presence.' ]); addBulletSlide('Computerized System Validation and eClinical QA', [ 'Validated EDC, CTMS, eTMF, and safety systems are essential.', 'Change control and regression testing protect validated state.', 'Role-based access and periodic user access review reduce risk.', 'Audit trails must be reviewable, attributable, and retained.' ]); addBulletSlide('CRO and Vendor Oversight', [ 'Sponsor remains accountable even when activities are outsourced.', 'Define oversight plan, governance cadence, and performance thresholds.', 'Review vendor quality metrics, audit outcomes, and CAPA closure status.', 'Escalate recurring performance issues with structured remediation.' ]); addBulletSlide('Key Quality Metrics and KRIs', [ 'Protocol deviation rate and recurrence trend.', 'Critical query aging and data turnaround times.', 'Consent error rate and retraining effectiveness.', 'Inspection/audit findings per site/vendor and closure timelines.' ]); addBulletSlide('CAPA Management', [ 'Document issue statement and immediate containment actions.', 'Perform root cause analysis (5 Why, fishbone, process mapping).', 'Define corrective and preventive actions with owners and due dates.', 'Verify effectiveness to ensure non-recurrence before closure.' ]); addBulletSlide('Inspection Readiness', [ 'Readiness is continuous, not a one-time pre-inspection event.', 'Maintain inspection narratives, evidence maps, and role-play Q&A.', 'Ensure consistency between source, eCRF, TMF, and safety databases.', 'Rapid retrieval of complete records is a core readiness indicator.' ]); addBulletSlide('Common Findings and Mitigations', [ 'Finding: Late safety reporting → Mitigation: automated alerts + backup roles.', 'Finding: Repeated consent errors → Mitigation: focused retraining + QC gate.', 'Finding: Missing TMF docs → Mitigation: periodic reconciliation cadence.', 'Finding: Weak oversight → Mitigation: governance KPIs + escalation triggers.' ]); addBulletSlide('Quality Culture and Leadership', [ 'Quality is everyone’s responsibility, not only the QA department.', 'Leadership behavior sets expectations for data integrity and compliance.', 'Speak-up culture helps identify risks early without fear of blame.', 'Continuous learning converts findings into process improvement.' ]); addBulletSlide('Case Example: Risk Trigger to CAPA Closure', [ 'Signal: rising protocol deviations at high-enrolling site.', 'Action: centralized review identified training and workflow gaps.', 'CAPA: targeted retraining, checklist control, enhanced monitoring.', 'Outcome: deviation trend reduced and sustained over subsequent cycles.' ]); addBulletSlide('Key Takeaways', [ 'QA builds robust systems; QC confirms outputs meet expectations.', 'QbD and RBQM improve focus on participant safety and critical data.', 'Metrics and CAPA create measurable, sustainable quality improvement.', 'Consistent quality practices enable credible evidence and approvals.' ]); // 23 Thank You { const slide = pptx.addSlide(); slide.background = { color: colors.bgDark }; slide.addText('THANK YOU', { x: 1.2, y: 2.35, w: 10.9, h: 1.0, fontSize: 60, bold: true, color: 'FFFFFF', align: 'center', valign: 'mid' }); slide.addShape(pptx.ShapeType.line, { x: 4.2, y: 3.55, w: 4.9, h: 0, line: { color: colors.accent, pt: 2 } }); slide.addText('Questions and Discussion', { x: 1.2, y: 3.85, w: 10.9, h: 0.5, fontSize: 22, color: 'D6E1F2', align: 'center' }); slide.addText('Quality Assurance + Quality Control = Trial Excellence', { x: 1.2, y: 6.45, w: 10.9, h: 0.35, fontSize: 13, color: 'AABAD4', align: 'center' }); } pptx.writeFile({ fileName: '/home/daytona/workspace/qa-qc-clinical-trial/Quality_Assurance_and_Quality_Control_in_Clinical_Research_Trials_20plus.pptx' }); EOF node /home/daytona/workspace/qa-qc-clinical-trial/create_ppt_20plus.js

ls -la /home/daytona/workspace/ && ls -la /home/daytona/workspace/qa-qc-clinical-trial/

python - << 'PY' from pathlib import Path p=Path('/home/daytona/workspace/qa-qc-clinical-trial/create_ppt_20plus.js') s=p.read_text() insert=''' function addSimpleTableSlide(title, subtitle, headers, rows) { const slide = pptx.addSlide(); slide.background = { color: colors.bgLight }; addHeader(slide, title, subtitle); const tableData = [headers, ...rows]; slide.addTable(tableData, { x: 0.9, y: 1.5, w: 11.5, h: 4.9, border: { type: 'solid', pt: 1, color: 'C9D3E3' }, fill: 'FFFFFF', color: colors.textDark, fontSize: 13, valign: 'middle', align: 'left', colW: [2.8, 2.3, 3.2, 3.2], rowH: 0.55, autoFit: false }); slide.addText('Effective QA and QC systems ensure participant safety, data integrity, and regulatory compliance throughout the clinical trial lifecycle.', { x: 1.0, y: 6.55, w: 11.2, h: 0.35, fontSize: 12, italic: true, color: colors.primary, align: 'center' }); addFooter(slide); } ''' marker='function addBulletSlide(title, bullets, subtitle = \'\') {' s=s.replace(marker, insert+'\n'+marker) add_call='''\naddSimpleTableSlide( 'QA and QC Summary Table', 'Simple standard comparison for quick reference', [ { text: 'Aspect', options: { bold: true, fill: 'DDEBFF', align: 'center' } }, { text: 'QA', options: { bold: true, fill: 'DDEBFF', align: 'center' } }, { text: 'QC', options: { bold: true, fill: 'DDEBFF', align: 'center' } }, { text: 'Expected Outcome', options: { bold: true, fill: 'DDEBFF', align: 'center' } } ], [ ['Focus', 'Process', 'Output', 'Controlled and consistent trial execution'], ['Timing', 'Proactive', 'Reactive/Detective', 'Early prevention + timely correction'], ['Owner', 'QA/Quality Leadership', 'Operations/Data Teams', 'Shared accountability and faster closure'], ['Core Activities', 'SOPs, audits, training', 'Checks, reviews, reconciliation', 'Regulatory-ready data and documents'], ['Risk Impact', 'Reduces system failures', 'Catches execution errors', 'Improved safety and compliance confidence'] ] );\n''' anchor="addBulletSlide('Key Takeaways', [" s=s.replace(anchor, add_call+'\n'+anchor) s=s.replace("Quality_Assurance_and_Quality_Control_in_Clinical_Research_Trials_20plus.pptx","Quality_Assurance_and_Quality_Control_in_Clinical_Research_Trials_20plus_simple_standard.pptx") p.write_text(s) print('updated') PY node /home/daytona/workspace/qa-qc-clinical-trial/create_ppt_20plus.js

ls -la /home/daytona/workspace/ && mkdir -p /home/daytona/workspace/pre-site-visit-assignment && cat > /home/daytona/workspace/pre-site-visit-assignment/create_doc.js << 'EOF' const fs = require('fs'); const { Document, Packer, Paragraph, TextRun, HeadingLevel, AlignmentType, PageBreak, Table, TableRow, TableCell, WidthType, BorderStyle } = require('docx'); function heading(text, level = HeadingLevel.HEADING_1) { return new Paragraph({ text, heading: level, spacing: { after: 200 } }); } function para(text, opts = {}) { return new Paragraph({ children: [new TextRun({ text, size: 24 })], alignment: opts.align || AlignmentType.JUSTIFIED, spacing: { after: 180, line: 360 } }); } function bullet(text) { return new Paragraph({ text, bullet: { level: 0 }, spacing: { after: 120, line: 320 } }); } function pageTitle(text) { return new Paragraph({ children: [new TextRun({ text, bold: true, size: 30 })], alignment: AlignmentType.LEFT, spacing: { after: 220 } }); } const pages = []; // Page 1 pages.push( pageTitle('Pre-Site Visit Assignment in Clinical Research'), para('Student Name: ____________________________ Date: ____________________', { align: AlignmentType.LEFT }), para('Course/Program: Clinical Research Faculty: __________________________', { align: AlignmentType.LEFT }), para('This assignment presents a structured and practical pre-site visit approach for Clinical Research Associates (CRAs) and site management personnel. The purpose is to ensure that every monitoring visit begins with clear preparation, risk awareness, and a focused strategy that protects participant safety and data quality.'), para('A pre-site visit is not just a logistical step. It is a quality control and quality assurance activity that influences monitoring outcomes, protocol compliance, and inspection readiness. Proper planning before arriving at the site helps identify gaps early, reduce avoidable findings, and improve communication with investigators and coordinators.'), para('This document is organized in a simple note style and can be used for submission, revision, or field reference before routine, interim, or close-out visits.'), new Paragraph({ children: [new PageBreak()] }) ); // Page 2 pages.push( pageTitle('1. Objectives of a Pre-Site Visit'), para('The core objective is to prepare a focused monitoring plan before engaging with the site team. The monitor should clearly understand current site status, open risks, pending actions, and key protocol priorities.'), bullet('Review trial progress at site level before the visit.'), bullet('Prioritize patient safety and critical data checks.'), bullet('Track unresolved issues from the previous visit.'), bullet('Plan visit activities according to visit type and available time.'), bullet('Coordinate efficiently with site staff for smooth execution.'), para('When objectives are clear, on-site time is used effectively and the monitoring report becomes more meaningful and actionable.'), new Paragraph({ children: [new PageBreak()] }) ); // Page 3 pages.push( pageTitle('2. Essential Documents to Review Before Visit'), para('Document review is the foundation of pre-visit preparation. The CRA should review all essential records and system outputs relevant to the upcoming visit period.'), bullet('Protocol and latest amendments with implementation dates.'), bullet('Investigator Brochure updates and safety letters.'), bullet('Previous monitoring visit report and follow-up letter.'), bullet('Open action item tracker and CAPA status.'), bullet('Delegation log, staff training log, and GCP certificates.'), bullet('Informed consent form versions and approval status.'), bullet('Enrollment, screening failure, and withdrawal summary.'), bullet('SAE/SUSAR line listing and reporting timelines.'), para('A structured checklist should be used so that no critical document is missed before travel or remote-site preparation.'), new Paragraph({ children: [new PageBreak()] }) ); // Page 4 pages.push( pageTitle('3. Site Performance and Risk Review'), para('Before the visit, the monitor should perform a quick but meaningful risk review of site performance trends. This helps define what requires deeper verification during the visit.'), bullet('Enrollment pace vs target and randomization quality.'), bullet('Protocol deviations: frequency, severity, and repeat patterns.'), bullet('Query aging and unresolved data discrepancies.'), bullet('Missing or delayed source documentation entries.'), bullet('Drug accountability discrepancies or storage issues.'), bullet('Late safety reporting and causality documentation gaps.'), para('Risk-based thinking allows prioritization of critical-to-quality factors, especially informed consent, eligibility, primary endpoint data, and safety reporting.'), new Paragraph({ children: [new PageBreak()] }) ); // Page 5 pages.push( pageTitle('4. Communication and Visit Scheduling'), para('Communication with the site should be formal, clear, and sent in advance. A well-written visit confirmation email avoids delays and reduces confusion on visit day.'), bullet('Confirm visit date, start time, and expected duration.'), bullet('Share draft visit agenda and records required for review.'), bullet('Request availability of PI/Sub-I, study coordinator, pharmacist, and data entry staff.'), bullet('Confirm workspace, internet access, and source record availability.'), bullet('Clarify if remote access is needed for hybrid monitoring.'), para('The monitor should keep written communication evidence in the trial master file according to sponsor procedures.'), new Paragraph({ children: [new PageBreak()] }) ); // Page 6 (table) pages.push( pageTitle('5. Pre-Site Visit Preparation Table'), para('The table below provides a simple and standard checklist format that can be used before each visit.'), new Table({ width: { size: 100, type: WidthType.PERCENTAGE }, rows: [ new TableRow({ children: [ new TableCell({ children: [para('Task', { align: AlignmentType.LEFT })] }), new TableCell({ children: [para('Status', { align: AlignmentType.LEFT })] }), new TableCell({ children: [para('Evidence', { align: AlignmentType.LEFT })] }), new TableCell({ children: [para('Comments', { align: AlignmentType.LEFT })] }) ]}), ...[ ['Previous visit report reviewed', 'Done/Pending', 'Report version/date', ''], ['Open action items updated', 'Done/Pending', 'Tracker screenshot', ''], ['Protocol/ICF latest versions verified', 'Done/Pending', 'Version list', ''], ['Safety events reviewed', 'Done/Pending', 'SAE listing', ''], ['Data query status checked', 'Done/Pending', 'EDC export', ''], ['Drug accountability plan prepared', 'Done/Pending', 'IP log notes', ''], ['Visit agenda sent to site', 'Done/Pending', 'Email proof', ''] ].map(r => new TableRow({ children: r.map(c => new TableCell({ children: [new Paragraph({ text: c })] })) })) ] }), para('Sentence for assignment: Effective pre-site visit preparation ensures participant safety, data integrity, and protocol compliance throughout clinical trial conduct.'), new Paragraph({ children: [new PageBreak()] }) ); // Page 7 pages.push( pageTitle('6. On-Site Focus Areas Planned in Advance'), para('The monitor should predefine high-priority checks to avoid spending time on low-impact activities.'), bullet('Informed consent process and re-consent after amendments.'), bullet('Eligibility verification against inclusion/exclusion criteria.'), bullet('Source-to-CRF consistency for critical efficacy and safety data.'), bullet('Investigational product receipt, storage, dispensing, and return.'), bullet('Protocol deviation documentation and root-cause discussion.'), bullet('Staff delegation consistency with performed trial tasks.'), para('A pre-planned focus list improves consistency across visits and across different sites in multicenter studies.'), new Paragraph({ children: [new PageBreak()] }) ); // Page 8 pages.push( pageTitle('7. Common Pre-Visit Gaps and Preventive Actions'), para('Many monitoring inefficiencies are caused by gaps that could have been prevented during preparation.'), bullet('Gap: No review of previous actions. Preventive action: mandatory tracker review before scheduling.'), bullet('Gap: Incomplete agenda. Preventive action: standardized agenda template with role allocation.'), bullet('Gap: Unavailable PI during visit. Preventive action: confirm PI slot in writing at least 3 days prior.'), bullet('Gap: Late identification of data issues. Preventive action: pre-visit EDC listing review.'), bullet('Gap: Last-minute travel changes. Preventive action: backup remote monitoring plan.'), para('Preventive planning reduces stress for both monitor and site team, leading to more productive visits.'), new Paragraph({ children: [new PageBreak()] }) ); // Page 9 pages.push( pageTitle('8. Post-Preparation Output Before Departure'), para('Before departure, the monitor should finalize a concise readiness pack. This ensures nothing essential is forgotten and enables traceability.'), bullet('Final visit agenda with priorities and timeline.'), bullet('List of participants/records to be reviewed.'), bullet('Open issues and expected evidence list.'), bullet('Safety and deviation focus notes.'), bullet('Administrative logistics confirmation.'), bullet('Template for visit follow-up letter and action assignment.'), para('A standardized readiness output supports quality control, continuity across monitoring cycles, and smoother report writing after the visit.'), new Paragraph({ children: [new PageBreak()] }) ); // Page 10 pages.push( pageTitle('9. Conclusion and Assignment Reflection'), para('Pre-site visit assignment preparation is a critical professional skill in clinical research. It combines planning, quality awareness, communication, and regulatory thinking. Strong pre-visit preparation directly improves monitoring effectiveness and supports good clinical practice.'), para('Reflection points:'), bullet('How can risk-based planning improve your next monitoring visit?'), bullet('Which pre-visit checklist items are most often missed and why?'), bullet('What actions will you implement to improve consistency?'), para('Final Sentence: Effective pre-site visit preparation ensures participant safety, data integrity, and protocol compliance throughout clinical trial conduct.'), para('Signature: ____________________________'), para('Date: ____________________________') ); const doc = new Document({ sections: [{ properties: {}, children: pages }] }); Packer.toBuffer(doc).then((buffer) => { fs.writeFileSync('/home/daytona/workspace/pre-site-visit-assignment/Pre_Site_Visit_Assignment_Clinical_Research_10_Pages.docx', buffer); }); EOF node /home/daytona/workspace/pre-site-visit-assignment/create_doc.js